Policy / Pricing Eli Lilly issues data sharing ultimatum to 340B hospitals BioPharma DiveSelect hospitals have refused to share data to prove they re not double-dipping drug discounts, Lilly said.Read full story pharminent June 2, 2026 (Last updated: June 3, 2026) BioPharma Dive Select hospitals have refused to share data to prove they re not double-dipping drug discounts, Lilly said. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Fulcrum exploring a potential sale after FDA sidelined its sickle cell drugNext: ASCO26: In vivo CAR-Ts in the spotlight Related Stories Policy / Pricing US launches probe of German ‘underpayment’ for medicines pharminent June 19, 2026 Policy / Pricing FDA’s new voucher program hints at broader policy agenda, making many ‘uncomfortable’ pharminent June 19, 2026 Policy / Pricing German said to be backtracking on pharma rebate changes pharminent June 16, 2026
